CANbridge Pharmaceuticals CFO Steps Down
Company Announcements

CANbridge Pharmaceuticals CFO Steps Down

CANbridge Pharmaceuticals Inc. (HK:1228) has released an update.

CANbridge Pharmaceuticals Inc. has announced the resignation of Mr. Glenn Hassan as Chief Financial Officer effective September 30, 2024, for personal reasons, with no disagreements reported with the board. CEO Dr. James Qun Xue will cover the CFO role on an interim basis, supported by the finance team, until a new CFO is appointed. The company expressed appreciation for Mr. Hassan’s contributions during his tenure.

For further insights into HK:1228 stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App